Gene · 100861467
ERVK-13: endogenous retrovirus group K member 13
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. ERVK-13: endogenous retrovirus group K member 13. Genes, record 100861467. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/100861467
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,306
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ERVK-13 papers | Newest fiscal year |
|---|---|---|---|
| R01DK076690 | Complement-mediated injury of the kidney: New mechanisms and novel therapies | 20 | 2025 |
| R01AR051749 | Complement in the Pathogenesis of Autoimmune Arthritis | 14 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 8 | 2025 |
| I01RX000444 | Complement Factor H-based Therapeutic Strategies in Macular Degeneration | 6 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 6 | 2025 |
| P30EY005722 | Center Core Grant for Vision Research | 5 | 2025 |
| R01AI040459 | Post-Transplant Inflammatory Response | 5 | 2025 |
| ZIAHL006223 | The role of the intracellular complement system - the complosome - in Th1 biology | 5 | 2025 |
| P30AR073752 | Washington University Rheumatic Diseases Research Resource-based Center | 4 | 2025 |
| P30CA138313 | Medical University of South Carolina - Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,306Source NIH's project files
See all 1,306 nih grantsPapers3,774
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Definite DRESS following phenobarbital exposure with secondary HLH and DAT-positive hemolysis during high-dose IVIG treatment in a child. | Front Immunol | 2026 | 42774303 | PubTator, text mining | PubMed |
| Characterising prognostic complement biomarkers during clinical normothermic machine perfusion for renal transplantation. | Am J Transplant | 2026 | 42705465 | PubTator, text mining | PubMed |
| Probable Cold Agglutinin Disease Presenting With Profound Anemia and Cardiopulmonary Decompensation in a 93-Year-Old Woman: A Case Report. | Cureus | 2026 | 42703433 | PubTator, text mining | PubMed |
| Cold agglutinin disease: pathophysiology, diagnosis, and the evolving therapeutic landscape. | Blood Res | 2026 | 42696222 | PubTator, text mining | PubMed |
| Point-of-care assessment of complement activation in the ICU: a feasibility study of rapid terminal complement complex detection in critical illness. | Front Immunol | 2026 | 42643423 | PubTator, text mining | PubMed |
| Piperacillin-Induced Immune Hemolytic Anemia Masked by Intestinal Failure-Associated Liver Disease: A Case Report with Three Serial Exposures. | J Community Hosp Intern Med Perspect | 2026 | 42631292 | PubTator, text mining | PubMed |
| Standardized diagnostic approach for cold agglutinin disease: results from a Delphi-Based Expert Consensus. | Blood Transfus | 2026 | 42475661 | PubTator, text mining | PubMed |
| Case Report: Integrated genomic and immunological assays identify non-coding CFB variants in pneumococcal meningoencephalitis. | Front Immunol | 2026 | 42382763 | PubTator, text mining | PubMed |
| C5b-9 Deposition in Renal Transplant Biopsies Associates With Prolonged Delayed Graft Function in Kidneys Donated After Circulatory Death. | Transplantation | 2026 | 42302715 | PubTator, text mining | PubMed |
| Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapy. | Hemasphere | 2026 | 42255947 | PubTator, text mining | PubMed |
1 to 10 of 3,774
See all 3,774 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/100861467
GET https://conductscience.org/api/genes/v1/100861467/grants?page=2